Document Detail

Prevention of contrast-induced nephropathy with Na/K citrate.
MedLine Citation:
PMID:  23349296     Owner:  NLM     Status:  Publisher    
AimsContrast-induced nephropathy (CIN) is a frequent complication of many radiological procedures involving the application of contrast media. It represents a significant health problem that causes the increase in mortality, morbidity, and medical costs. For the prevention of CIN, a number of methods have been proposed to be effective. Among them, alkalinization of urine takes an important place. Although the Na/K citrate is a well-known agent for urine alkalinization, it has not been studied in the prevention of CIN.Methods and resultsTwo hundred and two patients who underwent coronary angiography were included in the study. They were randomized into groups receiving the drug Na/K citrate per os and to the control group. Serum creatinine and glomerular filtration rate were determined in all patients immediately before coronary angiography, and 48 h after the procedure. CIN criteria were a creatinine increase of >25%, reduction in the glomerular filtration rate by >25%, or an increase in serum creatinine of >44 μmol/L. The incidence of CIN in the group receiving Na/K citrate was significantly lower when compared with the control group (4% compared with 20%, P = 0.0001). Patients who had a urine pH <6 had a more than ten-fold higher incidence of contrast nephropathy compared with patients whose urine pH was >6.ConclusionAlkalinization of urine using the Na/K citrate may reduce the incidence of CIN.
Darko Markota; Ivica Markota; Boris Starcevic; Monika Tomic; Zrinko Prskalo; Ivica Brizic
Related Documents :
11133606 - Dexamethasone facilitates discharge after outpatient anorectal surgery.
23747486 - Association of sustained high plasma trough concentration of voriconazole with the inci...
23325966 - Evaluation of efficacy of oral pregabalin in reducing postoperative pain in patients un...
23683736 - Serial morphological and functional assessment of drug-eluting balloon for in-stent res...
10695286 - Prognostic indicators of childhood acute viral encephalitis.
968536 - Cardiac valve replacement in the first 21 years of life.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-24
Journal Detail:
Title:  European heart journal     Volume:  -     ISSN:  1522-9645     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Cardiology, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the...
Next Document:  Circulating angiopoietins and cardiovascular mortality in cardiogenic shock.